Report Detail

Other Global Cancer Targeted Therapy Market Data Survey Report 2013-2025

  • RnM3129233
  • |
  • 15 March, 2019
  • |
  • Global
  • |
  • 95 Pages
  • |
  • HeyReport
  • |
  • Other

Summary
The global Cancer Targeted Therapy market will reach xxx Million USD in 2019 with CAGR xx% 2019-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers profile, products & services, sales data of business
Global market size by Major Application
Global market size by Major Type
Key manufacturers are included based on company profile, sales data and product specifications etc.:
Advaxis 
Bind Therapeutics 
Boehringer Ingelheim 
Bristol Mayer Squibb 
Celldex Therapeutics 
Dendreon Corporation 
Eli Lily 
GalaxoSmithKline 
Galena Biopharma 
Genetech 
ImmunoCellular Therapeutics 
ImmunoGen 
Inovio Pharmaceuticals 
Johnson & Johnson 
NeoStem Oncology 
NewLink Genetics 
Northwest Biotherapeutics 
Merck 
Novartis 
Peregrine Pharmaceuticals 
Pfizer 
Roche 
Sanofi 
Seattle Genetics 
Teva
Major applications as follows:
Hospital 
Clinic 
Others
Major Type as follows:
Tumor Antigens As Targets of Antibodies 
Development of Antibodies for Clinical Purposes 
Complement Dependent Cytotoxicity (CDC) 
Signal Transduction Changes
Regional market size, production data and export & import:
Asia-Pacific
North America
Europe
South America
Middle East & Africa


Table of Contents

    1 Global Market Overview

    • 1.1 Scope of Statistics
      • 1.1.1 Scope of Products
      • 1.1.2 Scope of Manufacturers
      • 1.1.3 Scope of Application
      • 1.1.4 Scope of Type
      • 1.1.5 Scope of Regions/Countries
    • 1.2 Global Market Size

    2 Regional Market

    • 2.1 Regional Production
    • 2.2 Regional Demand
    • 2.3 Regional Trade

    3 Key Manufacturers

    • 3.1 Advaxis
      • 3.1.1 Company Information
      • 3.1.2 Product & Services
      • 3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.1.4 Recent Development
    • 3.2 Bind Therapeutics
      • 3.2.1 Company Information
      • 3.2.2 Product & Services
      • 3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.2.4 Recent Development
    • 3.3 Boehringer Ingelheim
      • 3.3.1 Company Information
      • 3.3.2 Product & Services
      • 3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.3.4 Recent Development
    • 3.4 Bristol Mayer Squibb
      • 3.4.1 Company Information
      • 3.4.2 Product & Services
      • 3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.4.4 Recent Development
    • 3.5 Celldex Therapeutics
      • 3.5.1 Company Information
      • 3.5.2 Product & Services
      • 3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.5.4 Recent Development
    • 3.6 Dendreon Corporation
      • 3.6.1 Company Information
      • 3.6.2 Product & Services
      • 3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.6.4 Recent Development
    • 3.7 Eli Lily
      • 3.7.1 Company Information
      • 3.7.2 Product & Services
      • 3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.7.4 Recent Development
    • 3.8 GalaxoSmithKline
      • 3.8.1 Company Information
      • 3.8.2 Product & Services
      • 3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.8.4 Recent Development
    • 3.9 Galena Biopharma
      • 3.9.1 Company Information
      • 3.9.2 Product & Services
      • 3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.9.4 Recent Development
    • 3.10 Genetech
      • 3.10.1 Company Information
      • 3.10.2 Product & Services
      • 3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.10.4 Recent Development
    • 3.11 ImmunoCellular Therapeutics
      • 3.11.1 Company Information
      • 3.11.2 Product & Services
      • 3.11.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.11.4 Recent Development
    • 3.12 ImmunoGen
      • 3.12.1 Company Information
      • 3.12.2 Product & Services
      • 3.12.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.12.4 Recent Development
    • 3.13 Inovio Pharmaceuticals
      • 3.13.1 Company Information
      • 3.13.2 Product & Services
      • 3.13.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.13.4 Recent Development
    • 3.14 Johnson & Johnson
      • 3.14.1 Company Information
      • 3.14.2 Product & Services
      • 3.14.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.14.4 Recent Development
    • 3.15 NeoStem Oncology
      • 3.15.1 Company Information
      • 3.15.2 Product & Services
      • 3.15.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.15.4 Recent Development
    • 3.16 NewLink Genetics
      • 3.16.1 Company Information
      • 3.16.2 Product & Services
      • 3.16.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.16.4 Recent Development
    • 3.17 Northwest Biotherapeutics
      • 3.17.1 Company Information
      • 3.17.2 Product & Services
      • 3.17.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.17.4 Recent Development
    • 3.18 Merck
      • 3.18.1 Company Information
      • 3.18.2 Product & Services
      • 3.18.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.18.4 Recent Development
    • 3.19 Novartis
      • 3.19.1 Company Information
      • 3.19.2 Product & Services
      • 3.19.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.19.4 Recent Development
    • 3.20 Peregrine Pharmaceuticals
      • 3.20.1 Company Information
      • 3.20.2 Product & Services
      • 3.20.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.20.4 Recent Development
    • 3.21 Pfizer
      • 3.21.1 Company Information
      • 3.21.2 Product & Services
      • 3.21.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.21.4 Recent Development
    • 3.22 Roche
      • 3.22.1 Company Information
      • 3.22.2 Product & Services
      • 3.22.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.22.4 Recent Development
    • 3.23 Sanofi
      • 3.23.1 Company Information
      • 3.23.2 Product & Services
      • 3.23.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.23.4 Recent Development
    • 3.24 Seattle Genetics
      • 3.24.1 Company Information
      • 3.24.2 Product & Services
      • 3.24.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    • 3.25 Teva
      • 3.25.1 Company Information
      • 3.25.2 Product & Services
      • 3.25.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

    4 Major Application

    • 4.1 Hospital
      • 4.1.1 Overview
      • 4.1.2 Hospital Market Size and Forecast
    • 4.2 Clinic
      • 4.2.1 Overview
      • 4.2.2 Clinic Market Size and Forecast
    • 4.3 Others
      • 4.3.1 Overview
      • 4.3.2 Others Market Size and Forecast

    5 Market by Type

      5.By Tumor Antigens As Targets of Antibodies

      • 5.1 Tumor Antigens As Targets of Antibodies
        • 5.1.1 Overview
        • 5.1.2 Tumor Antigens As Targets of Antibodies Market Size and Forecast
      • 5.2 Development of Antibodies for Clinical Purposes
        • 5.2.1 Overview
        • 5.2.2 Development of Antibodies for Clinical Purposes Market Size and Forecast
      • 5.3 Complement Dependent Cytotoxicity (CDC)
        • 5.3.1 Overview
        • 5.3.2 Complement Dependent Cytotoxicity (CDC) Market Size and Forecast
      • 5.4 Signal Transduction Changes
        • 5.4.1 Overview
        • 5.4.2 Signal Transduction Changes Market Size and Forecast

      6 Price Overview

      • 6.1 Price by Manufacturers
      • 6.2 Price by Application
      • 6.3 Price by Type

      7 Conclusion

      Summary:
      Get latest Market Research Reports on Cancer Targeted Therapy . Industry analysis & Market Report on Cancer Targeted Therapy is a syndicated market report, published as Global Cancer Targeted Therapy Market Data Survey Report 2013-2025. It is complete Research Study and Industry Analysis of Cancer Targeted Therapy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $1,500.00
      $2,000.00
      $3,000.00
      1,198.50
      1,598.00
      2,397.00
      1,392.00
      1,856.00
      2,784.00
      233,790.00
      311,720.00
      467,580.00
      125,355.00
      167,140.00
      250,710.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report